WXH-520

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWXH-520
Drug Alias NameER-alpha/VEGFR dual inhibitor (China Pharmaceutical University)WXH-520
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsEstrogen receptor alpha degraders
TargetsVascular endothelial growth factor receptorEstrogen receptor alpha
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChina Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A